Virus News and Research

Latest Virus News and Research

$In a fractious rerun, GOP rivals Haley and Desantis debate health care. Trump sits it out.$

In a fractious rerun, GOP rivals Haley and Desantis debate health care. Trump sits it out.

The race to win the quickly approaching Iowa caucuses was the theme running through Wednesday night's Republican presidential debate hosted by CNN at Drake University in Des Moines, Iowa. Front-runner Donald Trump was again absent and only two other candidates made the cut: Florida Gov. Ron DeSantis and former South Carolina Gov. Nikki Haley.

11 Jan 2024

Extended liver preservation technique shows promise for daytime transplants

Phase II clinical trial evaluates the safety and feasibility of prolonged DHOPE for extending human donor liver preservation to 20 hours, showing potential for facilitating daytime liver transplantation.

11 Jan 2024

Duration of virus exposure plays a major role in COVID-19 transmission, study finds

A study published today in Nature shows that the NHS COVID-19 contact tracing app successfully predicted people's risk of catching the virus following exposure to an infected person.

11 Jan 2024

A universal coronavirus vaccine could provide substantial health and economic benefits

What if scientists had developed a universal coronavirus vaccine in the years prior to 2020 so that it was available at the start of the COVID-19 pandemic?

11 Jan 2024

Blocking sugar molecules stops flu virus spread in mice

Scientists have long known that some viruses and bacteria begin infections by latching first onto sugar molecules on the surfaces of cells lining the sinuses and throat of mammals, including humans.

11 Jan 2024

BNT162b2 vaccine effectiveness in preventing SARS-CoV-2 infection and severe disease

The BNT162b2 vaccine’s effectiveness in preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

11 Jan 2024

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

In our latest interview, News-Medical speaks with Rosanna Zhang from ACROBiosystems about utilizing organoids for disease modeling in the field of neuroscience research.

From ACROBiosystems 11 Jan 2024

Study shows engineered antibodies significantly boost Omicron neutralization

Researchers engineered IgA antibodies from IgG monoclonals, enhancing neutralization against Omicron by up to 75-fold and offering protection in mice models.

10 Jan 2024

Pangolins' genetic makeup linked to increased coronavirus susceptibility

Research reveals pangolins' vulnerability to coronavirus due to innate immune gene pseudogenization, impacting their antiviral response.

10 Jan 2024

Research reveals how light can help destroy infectious coronavirus particles

New research has revealed how light can be used to destroy infectious coronavirus particles that contaminate surfaces.

10 Jan 2024

New intranasal vaccine candidate triggers powerful mucosal defense against SARS-CoV-2

A team of scientists, led by Duke-NUS Medical School, has discovered a potential intranasal vaccine candidate that provides improved, longer-lasting immunity against SARS-CoV-2 viruses compared to when given as an injection.

10 Jan 2024

Study: Respiratory syncytial virus directly infects nerve cells and causes inflammation

Respiratory syncytial virus (RSV), a common infection in children and senior adults, can also infect nerve cells and trigger inflammation leading to nerve damage, according to a new Tulane University study.

10 Jan 2024

Nasal drops with IgA antibodies may protect against COVID-19 and future variants

Researchers at Karolinska Institutet in Sweden have shown that nasal drops with IgA antibodies can protect mice from SARS-CoV-2 infection.

10 Jan 2024

New study finds maternal vaccine and monoclonal antibody effective against RSV in infants

The impact and cost-effectiveness of maternal vaccination (MV) to long-acting monoclonal antibody (la-mAB) therapy.

10 Jan 2024

New Omicron subvariants test vaccine limits, reveal unique infection challenges

Study reveals that the Omicron subvariants BA.2.86 and FLip show unique mutations and infectivity profiles, with BA.2.86 being highly infectious and resistant to most conventional antibodies, underscoring the need for updated vaccines.

9 Jan 2024

Breakthrough in gene editing: Enhanced virus-like particles promise new era in genetic disease treatment

Researchers developed an advanced prime editor-engineered virus-like particle (PE-eVLP) system, significantly enhancing gene editing efficiency in human cells and showing potential for treating genetic diseases.

9 Jan 2024

Zika virus effective in eliminating neuroblastoma tumors in mice, study finds

Injecting neuroblastoma tumors with Zika virus shrank or eliminated those tumors in studies with mice, suggesting that the virus could someday serve as an effective cancer therapy, according to a study led by Nemours Children's Health researchers and published today in Cancer Research Communications, a journal of the American Association for Cancer Research.

9 Jan 2024

New study sheds light on the biological properties of new COVID variant Pirola

Despite the end of the pandemic, COVID-19 continues to pose a serious health threat. Most individuals have established robust immune protection and do not develop severe disease but the infection can still lead to marked and sometimes long-lasting disease symptoms.

9 Jan 2024

Real-world study tracks vaccine's power to protect kids from Delta and Omicron variants

Children and adolescents who received one of the main COVID-19 vaccines were significantly protected from the illness and showed no increased signs of cardiac complications compared to young people who were not vaccinated, according to a new real-world study led by researchers from the Perelman School of Medicine at the University of Pennsylvania and Children's Hospital of Philadelphia (CHOP).

9 Jan 2024

SARS-CoV-2 BA.2.86 shows increased lung targeting despite vaccine effectiveness

New research shows that the recently emerged BA.2.86 omicron subvariant of the virus that causes COVID-19 can be neutralized by bivalent mRNA vaccine-induced antibodies in the blood, which explains why this variant did not cause a widespread surge as previously feared.

8 Jan 2024

Previous
1
...
59
60
61
62
63
64
65
...
1553
Next

Virus News and Research

Latest Virus News and Research

In a fractious rerun, GOP rivals Haley and Desantis debate health care. Trump sits it out.

Extended liver preservation technique shows promise for daytime transplants

Duration of virus exposure plays a major role in COVID-19 transmission, study finds

A universal coronavirus vaccine could provide substantial health and economic benefits

Blocking sugar molecules stops flu virus spread in mice

BNT162b2 vaccine effectiveness in preventing SARS-CoV-2 infection and severe disease

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Study shows engineered antibodies significantly boost Omicron neutralization

Pangolins' genetic makeup linked to increased coronavirus susceptibility

Research reveals how light can help destroy infectious coronavirus particles

New intranasal vaccine candidate triggers powerful mucosal defense against SARS-CoV-2

Study: Respiratory syncytial virus directly infects nerve cells and causes inflammation

Nasal drops with IgA antibodies may protect against COVID-19 and future variants

New study finds maternal vaccine and monoclonal antibody effective against RSV in infants

New Omicron subvariants test vaccine limits, reveal unique infection challenges

Breakthrough in gene editing: Enhanced virus-like particles promise new era in genetic disease treatment

Zika virus effective in eliminating neuroblastoma tumors in mice, study finds

New study sheds light on the biological properties of new COVID variant Pirola

Real-world study tracks vaccine's power to protect kids from Delta and Omicron variants

SARS-CoV-2 BA.2.86 shows increased lung targeting despite vaccine effectiveness

A new way of characterising biomolecules eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Newsletters you may be interested in